Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSolvonis Therap Regulatory News (SVNS)

Share Price Information for Solvonis Therap (SVNS)

Share Price is delayed by 15 minutes
Get Live Data
0.215    -0.001 (-0.47%)
Bid:
0.21
Ask:
0.22
Spread: 0.01 (4.762%)
Market Cap: £14.36m
SVNS Live PriceLast checked at - London Stock Exchange

Intraday Solvonis Therap Share Chart

12
Date   Source Headline
27th May 202612:00 pmRNSNotice of Annual General Meeting
5th May 20267:00 amRNS-RCSO Speaks at National Research Meeting
29th Apr 20267:00 amRNSFinal Results
22nd Apr 20267:00 amRNS-RAppointment of Water Tower Research
20th Apr 20268:32 amRNS-RUS CNS Executive Order
8th Apr 20267:00 amRNSGranted U.S. Patent from PTSD Discovery Programme
31st Mar 20267:00 amRNSGranted U.S. Patent from PTSD Discovery Programme
10th Mar 20267:00 amRNSSVN-114 selected for PTSD discovery programme
28th Jan 20267:00 amRNSExpansion of SVN-015 into depression
7th Jan 20267:00 amRNSUS Patent allowance for PTSD discovery programme
22nd Dec 20257:00 amRNSResearch and Development Update - Q4 2025
22nd Dec 20257:00 amRNSResearch and Development Update – Q4 2025
3rd Dec 20257:00 amRNSSVN-015 accepted into US NIDA funded programme
31st Oct 20253:59 pmRNSTotal Voting Rights
31st Oct 20257:00 amRNSCorporate Structure Update and Issue of Options
27th Oct 20257:00 amRNSAppoints global biopharma leader Paul Carter
16th Oct 20257:00 amRNSRaises £1.25 Million to Accelerate Programmes
30th Sep 20257:00 amRNSHalf-year Report
28th Aug 20257:00 amRNSSolvonis secures exclusive CNS collaboration
13th Aug 20253:03 pmRNS-RMedia Coverage: Small Cap Idea profile
12th Aug 20257:00 amRNSSVN-SDN-14 PTSD - Positive pre-clinical results
31st Jul 20254:30 pmRNSTotal Voting Rights
22nd Jul 20257:00 amRNSTranslational Bridging Studies
18th Jul 202511:03 amRNSExercise of warrants
14th Jul 20257:00 amRNS-RSolvonis Chair to speak at Lucid Capital Markets
11th Jul 20257:00 amRNS£1m subscription to accelerate AI drug discovery
8th Jul 20257:00 amRNSHolding(s) in Company
27th Jun 20252:38 pmRNSAGM Statement
27th Jun 20258:54 amRNSHolding(s) in Company
26th Jun 202510:21 amRNS-RInitiation of Research Coverage
23rd Jun 20257:00 amRNSAllowance of U.S. patent covering AI-supported CNS
11th Jun 20257:30 amRNSInitiation of AI supported CNS drug discovery
5th Jun 20257:00 amRNSSynthesis of development candidate for SVN-SDN-014
3rd Jun 20254:30 pmRNSNotice of Annual General Meeting
3rd Jun 20257:00 amRNSAppointment of Prof. David Nutt as CSO
2nd Jun 202511:58 amRNSHolding(s) in Company
30th May 20255:00 pmRNSTotal Voting Rights
29th May 20253:11 pmRNSHolding(s) in Company
29th May 202512:02 pmRNSHolding(s) in Company
29th May 202510:30 amRNSHolding(s) in Company
29th May 20257:00 amRNS-RPresentation at Mello2025
28th May 20257:30 amRNSHolding(s) in Company
28th May 20257:00 amRNSCompletion of the acquisition of Awakn
21st May 20253:24 pmRNSPublication of a Prospectus
16th May 20257:31 amRNSResult of placing
15th May 20254:53 pmRNSProposed equity fundraising via ABB
28th Apr 202511:30 amRNSResult of General Meeting
23rd Apr 20257:00 amRNSProposed acquisition of Awakn approved
16th Apr 20257:00 amRNSFinal Results for the year ended 31 December 2024
10th Apr 20252:00 pmRNSPosting of Circular and Notice of General Meeting
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.